Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

Glioblastoma is the deadliest primary malignant brain neoplasm, and despite the availability of many treatment options, its prognosis remains somber. Enhancement detected by magnetic resonance imaging (MRI) was considered the best imaging marker of tumor activity in glioblastoma for decades. However...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Arevalo, Octavio D., Soto, Carolina, Rabiei, Pejman, Kamali, Arash, Ballester, Leomar Y., Esquenazi, Yoshua, Zhu, Jay-Jiguang, Riascos, Roy Francisco
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514158/
https://ncbi.nlm.nih.gov/pubmed/31133966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.00460
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados